News
DRIO
7.33
-2.01%
-0.15
DarioHealth Price Target Cut to $8.00/Share From $11.00 by TD Cowen
Dow Jones · 1d ago
DarioHealth Is Maintained at Hold by TD Cowen
Dow Jones · 1d ago
TD Cowen Maintains Hold on DarioHealth, Lowers Price Target to $8
Benzinga · 1d ago
DarioHealth Q2 Loss Narrows Despite Revenue Decline; To Launch Women And Sleep Programs In Q4 '26
NASDAQ · 1d ago
DarioHealth (DRIO) Receives a Hold from TD Cowen
TipRanks · 2d ago
DarioHealth trading resumes
TipRanks · 2d ago
DarioHealth trading halted, volatility trading pause
TipRanks · 2d ago
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates
NASDAQ · 2d ago
DarioHealth GAAP EPS of -$0.85 beats by $0.37, revenue of $5.18M misses by $0.48M
Seeking Alpha · 2d ago
Weekly Report: what happened at DRIO last week (0803-0807)?
Weekly Report · 3d ago
Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
PR Newswire · 08/04 11:30
DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026
PR Newswire · 08/03 10:30
Weekly Report: what happened at DRIO last week (0727-0731)?
Weekly Report · 08/03 09:55
DarioHealth launches integrated GLP-1 Program
TipRanks · 07/30 11:50
DarioHealth Launches GLP-1 Program, With Commercial Availability Expected Fall 2026, With Revenue Contribution From Late 2026 And Ramping Through 2027
Benzinga · 07/30 11:37
DarioHealth Insider Makes Bold Move With Fresh Share Purchase
TipRanks · 07/29 02:02
Weekly Report: what happened at DRIO last week (0720-0724)?
Weekly Report · 07/27 09:58
Thermo Fisher Scientific (TMO) Surpasses Q2 Earnings and Revenue Estimates
NASDAQ · 07/23 11:15
DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last?
NASDAQ · 07/23 09:40
Top Biotech Gainers: ZCMD Surges 190%, LABT Advances On Nu-3 Progress, ARWR Hits The Targets
NASDAQ · 07/23 03:09
More
Webull provides a variety of real-time DRIO stock news. You can receive the latest news about Dariohealth Corp through multiple platforms. This information may help you make smarter investment decisions.
About DRIO
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.